small molecule

NAFTIFINE HYDROCHLORIDE

NAFTIFINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyAmneal Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameNAFTIFINE HYDROCHLORIDE
Active ingredientNAFTIFINE HYDROCHLORIDE
Strength1%
Dosage formGEL
RouteTOPICAL
ModalitySmall molecule
FDA approvalMarch 2019
Marketing statusDISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.